MaxCyte, Inc. (MXCT)

MaxCyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	15.04	20.07	27.88	46.51	11.07	47.78
Short-Term Investments	90.65	82.98	126.6	121.78	216.28	207.26
Cash & Short-Term Investments	105.69	103.04	154.48	168.29	227.34	255.04
Cash Growth	-16.49%	-33.30%	-8.20%	-25.97%	-10.86%	633.67%
Accounts Receivable	3.92	3.5	4.68	5.78	11.18	6.88
Other Receivables	-	-	-	-	1.91	-
Receivables	3.92	3.5	4.68	5.78	13.09	6.88
Inventory	7.8	7.55	8.91	12.23	8.58	5.2
Prepaid Expenses	3.66	4.28	3.61	3.9	3.26	3.31
Other Current Assets	0.2	-	-	-	-	-
Total Current Assets	121.27	118.37	171.68	190.19	252.27	270.43
Property, Plant & Equipment	25.37	28.45	30.47	34.75	33.58	13.37
Long-Term Investments	36.23	52.57	35.78	42.94	-	-
Other Intangible Assets	0.77	0.65	-	-	-	-
Other Long-Term Assets	1.03	2.47	1.53	0.39	0.81	0.32
Total Assets	184.67	202.51	239.47	268.27	286.65	284.12

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.73	1.4	1.36	0.74	0.29	1.82
Accrued Expenses	4.17	7.81	8.3	11.27	8.27	6.52
Current Portion of Leases	1.53	1.46	0.86	0.77	0.16	0.53
Current Unearned Revenue	2.46	3.6	5.25	5.07	6.71	6.75
Total Current Liabilities	9.9	14.27	15.78	17.86	15.43	15.62
Long-Term Leases	15.72	16.49	17.17	17.97	15.94	5.15
Other Long-Term Liabilities	0.3	0.26	0.27	0.28	1.32	0.45
Total Liabilities	25.92	31.02	33.22	36.11	32.69	21.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.07	1.07	1.06	1.04	1.02	1.01
Additional Paid-In Capital	434.26	431.91	422.05	406.93	390.82	376.19
Retained Earnings	-275.11	-261.48	-216.85	-175.8	-137.88	-114.3
Total Common Equity	158.75	171.49	206.25	232.17	253.97	262.9
Shareholders' Equity	158.75	171.49	206.25	232.17	253.97	262.9
Total Liabilities & Equity	184.67	202.51	239.47	268.27	286.65	284.12

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	17.25	17.94	18.03	18.74	16.1	5.68
Net Cash (Debt)	88.44	85.1	136.45	149.55	211.25	249.36
Net Cash Growth	-18.15%	-37.63%	-8.76%	-29.21%	-15.29%	797.10%
Net Cash Per Share	0.83	0.80	1.30	1.45	2.08	2.75
Filing Date Shares Outstanding	103.21	106.86	106.03	104.13	102.9	101.51
Total Common Shares Outstanding	106.13	106.79	105.71	103.96	102.4	101.2
Working Capital	111.38	104.1	155.91	172.34	236.84	254.82
Book Value Per Share	1.50	1.61	1.95	2.23	2.48	2.60
Tangible Book Value	157.99	170.84	206.25	232.17	253.97	262.9
Tangible Book Value Per Share	1.49	1.60	1.95	2.23	2.48	2.60
Machinery	11.99	14.47	13.95	14.73	11.96	8.12
Construction In Progress	0.02	0.91	0.27	0.31	0.63	1.16
Leasehold Improvements	14.79	14.79	14.73	14.65	14.2	0.64

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error